|
Delayed
NYSE
14:39:40 2026-11-17 EST
|
5-day change | 1st Jan Change | ||
| 95.36 USD | -0.48% |
|
-4.28% | +16.08% |
Main features
| US46137V7872 | Fees | 0.58% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (CAD) | 595.82M | Replication Method | Direct (Physical) |
| Number of securities | 29 | AuM evolution | - | Date of creation | 2005-06-22 |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
CBOE
| PBE | Real-time | |
NYSE
| PBE | Delayed | |
Tradegate
| P3W1 | Real-time |
662e02bea8ff1e.DVQwDHNrqgEBp14yzKGtfvsQDjmLVmJw0OvdrlFzUqQ.WzhifyMy20xEkTRTisrIEMl7Zl_qe08i466-2wM7MOtUNR17SiPeS0jJbg
| Name |
Indicative Price |
Change |
Weight | |
|---|---|---|---|---|
| 169.59USD | +1.20% | 5.92% | ||
| 456.58USD | -1.24% | 5.86% | ||
| 249.49USD | -0.86% | 5.49% | ||
| 580.87USD | -1.19% | 5.45% | ||
| 954.95USD | +0.27% | 5.23% | ||
| 200.53USD | +1.28% | 5.22% | ||
| 119.63USD | -0.53% | 4.86% | ||
| 14.49USD | +0.21% | 4.08% | ||
| 156.16USD | -2.24% | 3.94% | ||
| 7.465USD | +0.20% | 3.26% | ||
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | BioTech & Genomics |
The Invesco Dynamic Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-17 | US$95.36 | -0.48% | 19,183 |
| 26-11-16 | US$95.82 | -2.10% | 8,314 |
| 26-11-13 | US$97.88 | -0.56% | 6,139 |
| 26-11-12 | US$98.43 | -1.84% | 3,470 |
| 26-11-11 | US$100.27 | +0.65% | 55,609 |
- Stock Market
- ETF
- PBE ETF
Select your edition
All financial news and data tailored to specific country editions
























